US Stock MarketDetailed Quotes
MTEM Molecular Templates
- 0.3353
- -0.0447-11.76%
Close Nov 22 16:00 ET
- 0.3400
- +0.0047+1.40%
Post 20:01 ET
2.21MMarket Cap-109P/E (TTM)
0.4390High0.3325Low7.99MVolume0.4200Open0.3800Pre Close3.27MTurnover176.80%Turnover RatioLossP/E (Static)6.58MShares5.370052wk High0.31P/B1.52MFloat Cap0.295052wk Low--Dividend TTM4.52MShs Float16810.1847Historical High--Div YieldTTM28.03%Amplitude0.2950Historical Low0.4090Avg Price1Lot Size
About Molecular Templates Company
Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. The company was founded by Eric E. Poma, Jean Gariépy, and Leigh Revers in 2001 and is headquartered in Austin, TX.
Company Profile
SymbolMTEM
Company NameMolecular Templates
Listing DateFeb 4, 2005
Issue Price7.00
Founded2000
CEODr. Eric E. Poma, PhD
MarketNASDAQ
Employees62
Fiscal Year Ends12-31
Address9301 Amberglen Boulevard,Suite 100
CityAustin
ProvinceTexas
CountryUnited States of America
Zip Code78729
Phone1-512-869-1555
Websitehttp://www.mtem.com
Company Executives
- Name
- Position
- Salary
- Dr. Eric E. Poma, PhD
- Director, Chief Executive Officer and Chief Scientific Officer
- 857.77K
- Dr. Gabriela Gruia, M.D.
- Interim Chief Medical Officer and Director
- 190.54K
- Jason S. Kim
- President, Chief Financial Officer, Treasurer and Principal Accounting Officer
- 579.24K
- Dr. Harold E. Selick, PhD
- Chairman of the Board
- 87.29K
- David R. Hoffmann
- Independent Director
- 59.29K
- Dr. Corazon Dating Sanders, PhD
- Independent Director
- 49.29K
- Kevin M. Lalande
- Independent Director
- 54.29K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data